Archive for the ‘stem cells’ tag
Sep 26, 2019
Human Embryoid Research! — Dr. Deborah Gumucio, Ph.D — University of Michigan — ideaXme — Ira Pastor
Posted by Ira S. Pastor in categories: 3D printing, aging, bioengineering, bioprinting, biotech/medical, complex systems, DNA, genetics, health, transhumanism
Aug 30, 2019
The Regenerage Show — Episode #2 — “What Causes Biological Aging?” — Host — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, cryonics, DNA, genetics, health, life extension, transhumanism
Jul 23, 2019
Dr. Calixto Machado, MD. PhD. Clinical Neurophysiology and Neurology; Author of “Brain Death: A Reappraisal” — ideaXme Show — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, cryonics, DNA, life extension, neuroscience, science, transhumanism
Jun 2, 2019
Dr. Camillo Ricordi, M.D. — Director, Diabetes Research Institute and Cell Transplant Center, University of Miami — ideaXme — Ira Pastor
Posted by Ira S. Pastor in categories: 3D printing, aging, bioengineering, biotech/medical, business, DNA, genetics, health, life extension, science
Apr 18, 2019
Dr. Doris Taylor — Texas Heart Institute — IdeaXme — Ira Pastor — “How to Build a New Heart”
Posted by Ira S. Pastor in categories: 3D printing, aging, bioengineering, biotech/medical, chemistry, cryonics, DNA, genetics, health, life extension
Dec 8, 2018
Regenerage — SMX Radio — The Net of Regenerative Medicine — Bioquark
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, finance, futurism, genetics, life extension
Dr. Joel I. Osorio of RegenerAge Clinic on SMX Radio broadcasting from the Colonia Santa María la Ribera neighborhood of Mexico City -
“LAS NETAS DE LA MEDICINA REGENERATIVA” (The Net of Regenerative Medicine)
Continue reading “Regenerage — SMX Radio — The Net of Regenerative Medicine — Bioquark” »
Oct 25, 2018
Regenerage — Spinal Cord Regeneration — Venga la Alegria — TV Azteca — Bioquark Inc.
Posted by Ira S. Pastor in categories: bioengineering, biotech/medical, chemistry, disruptive technology, DNA, futurism, genetics, health, nanotechnology, neuroscience
Wonderful to see the continuing progress of Mr. Omar Flores, with the support of his lovely wife, actress Mayra Sierra, today on the Venga la Alegria (VLA) show on TV Azteca (http://www.aztecauno.com/vengalaalegria) — The importance of an integrated approach to curing spinal cord injury including family, physical therapists, and the medical team at Regenerage (https://regenerage.clinic/)
Wonderful to see the continuing progress of Mr. Omar Flores, with the support of his lovely wife, actress Mayra Sierra, today on the Venga la Alegria (VLA) show on TV Azteca (Jun 7, 2018
The Neurogenesis Debate
Posted by Nicholi Avery in categories: biological, futurism, neuroscience
The Neurogenesis Debate
Written by Nicholi Avery
On March 7 2018, a study was published in the highly esteemed journal Nature by an international team of scientists claiming that #neurogenesis starts to rapidly decline in the #human brain as early as 13 years old and becomes undetectable in adults. This rocked the scientific community as there has been a long-established theory that neurogenesis takes place throughout the course of life in the mammalian #brain. Until the 1990s, neurologists were practicing their profession under the doctrine established in the late 19th to early 20th century by the prominent histologist Ramon y Cajal, often referred to as a god of neuroscience;
Feb 22, 2017
Bioquark Inc. and SC21 Biotech to Collaborate on Novel Cellular Therapies for Long Term HIV Control
Posted by Ira S. Pastor in categories: bioengineering, biotech/medical, business, disruptive technology, DNA, genetics, health, science, sex
Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm
Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.
“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”
